CITED2 and breast carcinoma: Extending this work to breast cancer in humans, we found that CITED2 expression in primary tumor and metastatic tissues was elevated relative to normal mammary epithelium, with CITED2 levels in primary tumors inversely correlating with patient survival [7, 16–17].